Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
02/10/2023* -- Results Q4 2022 -- 0.71 --
02/10/2023* 08:30 EST Earnings Call Q4 2022 -- -- --
11/03/2022 -- Results Q3 2022 0.66 0.56 18.61%
11/03/2022 08:30 EST Earnings Call Q3 2022 -- -- --
08/03/2022 -- Results Q2 2022 0.45 0.45 -0.04%
08/03/2022 16:30 EST Earnings Call Q2 2022 -- -- --
05/04/2022 -- Results Q1 2022 0.49 0.42 17.19%
05/04/2022 08:30 EST Earnings Call Q1 2022 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 02/10/2023 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 11/03/2022
Beat/Miss Upgrade
Return Since 4.31%
Last FQE 09/30/2022
Next FQE 12/30/2022

Profile

Edit
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker BioSpin Group, Bruker Calid Group, Bruker Scientific Instruments Nano, and Bruker Energy & Supercon Technologies. The Bruker BioSpin Group and Bruker Calid Group are aggregated into BSI Life Science segment for reporting purposes, and it provides the highest revenue stream to the firm. The largest proportion of Bruker's revenue comes from Europe, though the firm also has a significant presence in the United States and Asia. It has its major technical and manufacturing centers in Europe, North America, Southeast Asia, as well as sales offices throughout the world.
URL https://www.bruker.com
Investor Relations URL https://ir.bruker.com
HQ State/Province Massachusetts
Sector Healthcare
Industry Medical Devices
Equity Style Mid Cap/Growth
Next Earnings Release Feb. 10, 2023 (est.)
Last Earnings Release Nov. 03, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Nov. 30, 2022

Dividends

Dividend Per Share (TTM) 0.19
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.2313
Yield to Sector 0.1997
Yield to Industry 0.1907
Last Dividend Amt. 0.05
Dividend Frequency Quarterly
Last Ex-Dividend Date Nov. 30, 2022
Yield (TTM) 0.30%
Forward Yield 0.30%
Payout Ratio 10.33%
Cash Payout Ratio 23.97%
Consistent Payer (5Y) Yes
Consistent Growth (5Y) Yes

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
23.70%
-12.16%
62.96%
-12.82%
71.85%
6.58%
55.36%
-20.00%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-13.26%
15.01%
31.46%
30.94%
-2.70%
59.34%
57.54%
29.61%
-44.54%
23.22%
-2.12%
40.85%
7.80%
24.01%
48.19%
40.37%
-30.62%
-67.80%
-28.59%
-49.84%
-47.69%
-93.17%
229.0%
-48.60%
-56.50%
-87.17%
63.37%
16.67%
-79.93%
-17.17%
8.91%
-45.97%
-84.33%
As of December 02, 2022.

Profile

Edit
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker BioSpin Group, Bruker Calid Group, Bruker Scientific Instruments Nano, and Bruker Energy & Supercon Technologies. The Bruker BioSpin Group and Bruker Calid Group are aggregated into BSI Life Science segment for reporting purposes, and it provides the highest revenue stream to the firm. The largest proportion of Bruker's revenue comes from Europe, though the firm also has a significant presence in the United States and Asia. It has its major technical and manufacturing centers in Europe, North America, Southeast Asia, as well as sales offices throughout the world.
URL https://www.bruker.com
Investor Relations URL https://ir.bruker.com
HQ State/Province Massachusetts
Sector Healthcare
Industry Medical Devices
Equity Style Mid Cap/Growth
Next Earnings Release Feb. 10, 2023 (est.)
Last Earnings Release Nov. 03, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Nov. 30, 2022

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
DXZ.TO 232114.0 USD 3.60%
HELX 276329.0 USD 2.53%
FTHAX 96.91M USD 1.91%
FSMEX 120.98M USD 1.82%
FITE 490648.0 USD 1.70%
MJJ 724923.0 USD 1.48%
PMEGX 66.48M USD 1.46%
RRMGX 364.38M USD 1.42%
FVUSA04AZ9 65.48M USD 1.42%
KOMP 20.84M USD 1.28%
PASSX 60.44M USD 0.81%
IHI 39.02M USD 0.63%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Nasdaq Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter BRKR Tweets